Research and Development

The Food and Drug Administration has unveiled the first phase of its transparency initiative, designed to make its drug approval …

Dublin-headquartered biotech Amarin has appointed Joseph Zakrzewski executive chairman. He is currently the chief executive of Xcellerex, a Massachusetts-based biotechnology …

Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …

GlaxoSmithKline is to develop and commercialise a drug which hopes will be a treatment for moderate-to-severe Crohn’s disease. Californian biotech …

The Pharmafocus interview: Murray Lumpkin, FDA Deputy Commissioner for International ProgramsCollaborations between the world’s leading medicines regulators have increased markedly …

Oxford BioTherapeutics (OBT) has appointed Dr Michael Moore non-executive chairman. He joins the company following five years spent at UK …

Roche has signed a deal with Evolva Holding to create anti-infectives and cancer treatments using the latter’s genetic chemistry technology. Roche’s …

UK pharma industry association the ABPI has promoted Alison Clough to commercial and communications director. She moves into the new …

India’s Marksans Pharma is seeking approval from its shareholders to divest or lease out its two active pharmaceutical ingredient (API) …

Japanese drugmaker Eisai has started operations at a manufacturing and research facility in Visakhapatnam, southern India, which will be the …

Kendle has appointed Stephen Cutler to the position of senior vice president and chief operating officer.Dr Cutler has a track …

AstraZeneca is to buy infection research firm Novexel for $350 million. The manufacturer will take all the French company’s shares …

Woodley Equipment has appointed David Wood medical electronics manager and Joanne Platt as customer service representative. David will be instrumental …

An independent committee of directors of Alcon has expressed its disappointment with the recent takeover bid from Novartis, saying the …

Merck & Co has put a US public health and infectious diseases expert in charge of its $5 billion global …